QUERZOLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 10.040
AS - Asia 5.329
EU - Europa 3.889
SA - Sud America 887
AF - Africa 135
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.303
Nazione #
US - Stati Uniti d'America 9.786
SG - Singapore 2.059
CN - Cina 1.425
IT - Italia 1.158
BR - Brasile 696
DE - Germania 620
VN - Vietnam 567
UA - Ucraina 472
GB - Regno Unito 365
HK - Hong Kong 351
TR - Turchia 316
FI - Finlandia 249
PL - Polonia 216
SE - Svezia 192
FR - Francia 184
RU - Federazione Russa 136
CA - Canada 135
IN - India 125
JP - Giappone 120
MX - Messico 99
BD - Bangladesh 77
ID - Indonesia 77
NL - Olanda 63
BE - Belgio 61
AR - Argentina 56
ZA - Sudafrica 55
EC - Ecuador 36
ES - Italia 35
IQ - Iraq 33
PK - Pakistan 29
CO - Colombia 28
AT - Austria 26
CZ - Repubblica Ceca 24
MA - Marocco 23
VE - Venezuela 23
LT - Lituania 21
UZ - Uzbekistan 20
PH - Filippine 16
AU - Australia 15
MY - Malesia 15
CL - Cile 14
PY - Paraguay 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
KE - Kenya 11
SA - Arabia Saudita 11
TN - Tunisia 9
UY - Uruguay 9
AZ - Azerbaigian 7
BO - Bolivia 7
CH - Svizzera 7
IR - Iran 7
JO - Giordania 7
KZ - Kazakistan 7
NP - Nepal 7
CR - Costa Rica 6
KR - Corea 6
AL - Albania 5
AO - Angola 5
DZ - Algeria 5
IE - Irlanda 5
JM - Giamaica 5
OM - Oman 5
EU - Europa 4
GR - Grecia 4
HU - Ungheria 4
IL - Israele 4
MD - Moldavia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
ET - Etiopia 3
HR - Croazia 3
LY - Libia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
PS - Palestinian Territory 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
Totale 20.280
Città #
Singapore 1.293
Ashburn 1.131
Woodbridge 795
San Jose 711
Chandler 612
Fairfield 593
Ann Arbor 548
Jacksonville 502
Santa Clara 455
Beijing 425
Houston 396
Hong Kong 347
Wilmington 267
Seattle 252
New York 238
Warsaw 207
Izmir 198
Los Angeles 197
Cambridge 193
Dallas 187
Ho Chi Minh City 174
Munich 171
Nanjing 160
Hanoi 138
Tokyo 116
Princeton 113
Milan 103
Buffalo 96
Shanghai 92
Lauterbourg 91
Ferrara 89
Helsinki 83
Boardman 78
Council Bluffs 75
Nanchang 72
Turku 72
São Paulo 71
Bremen 69
Mexico City 65
Orem 65
Brooklyn 62
Dearborn 61
Brussels 60
San Diego 60
Jakarta 53
Montreal 50
Rome 50
Tianjin 49
Chennai 46
Shenyang 45
Hebei 41
Denver 38
London 38
Changsha 36
Chicago 36
Falls Church 36
Johannesburg 34
Toronto 34
Atlanta 32
Stockholm 32
Hefei 31
Manchester 31
Frankfurt am Main 29
Haiphong 29
The Dalles 29
Da Nang 28
Falkenstein 28
Bologna 27
Poplar 26
Rio de Janeiro 25
Boston 24
San Mateo 24
Zhengzhou 24
Jiaxing 23
Jinan 23
Redwood City 23
Phoenix 22
San Francisco 22
Auburn Hills 21
Guangzhou 21
Moscow 21
Amsterdam 20
Tashkent 18
Belo Horizonte 17
Nuremberg 17
Vienna 17
Brasília 16
New Delhi 16
Norwalk 16
Charlotte 15
Philadelphia 15
Querétaro 15
Ankara 14
City of London 14
Guayaquil 14
Mountain View 14
Addison 13
Brno 13
Ottawa 13
Baghdad 12
Totale 13.253
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 662
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 526
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 299
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 293
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 270
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 254
Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases 254
Breast Cancer and Simian Virus 40 Infection 253
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 249
CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer 236
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 234
Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation 229
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 227
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 225
CD8 + ve cell infiltration correlates with angiogenesis in non-small cell lung cancer (NSCLC) of patients with chronic obstructive pulmonary disease 224
miR-501 overexpression in renal carcinomas 222
Application of quantitative analysis to biologic profile evaluation in breast cancer 222
Serologic investigation on undifferentiated nasopharyngeal carcinoma and Simian Virus 40 infection 219
Espressione dell'oncoproteina virale antigene T-grande di SV40 in carcinomi mammari infiltranti valutata su Tissue micro arrays (TMAs) 215
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 214
Sentinel node study in early breast cancer 212
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 208
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 207
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 205
Core needle biopsy in invasive breast cancer prognostic/predictive power: concordance with surgical speciemen and impact of immunophenotypes 202
Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer 201
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 201
Factors responsible of scintigraphic false-negative sentinel lymph node detection in brest cancer 199
Espressione dei MicroRNA nei carcinomi mammari 198
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer 196
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer 196
Tumour-infiltrating CD8+ cells expressing IL-10, but not CD8+, CD4+ and CD68+ cells, are associated with a better prognosis in patients with NSCLC 194
The 70 Gene Mammaprint signature: Ferrara's experience 193
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 189
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 187
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 186
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer 186
Clinical-diagnostic meaning of mammary uptake accidentally detected during 18F-FDG PET/CT (PET): comparison between radiological imaging and histopathology. 186
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 185
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 185
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 184
Expression of IL-10 by CD8+ T Cells Is a Favorable Prognostic Factor in Non-Small Cell Lung Cancer 184
Quantitative immunoprofiles of breast cancer performed by image analysis 183
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 183
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 181
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 181
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 180
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-insitutional study in Italy 180
Biology and prognosis of 1685 recently diagnosed HER2 positive breast carcinomas 179
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 178
Prognostic and predictive factors related to metastatic breast cancer clinical history: an outcome study [Fattori prognostici e predittivi nella storia clinica del carcinoma metastatico della mammella: Uno studio di esito] 177
A case of invasive solid papillary breast carcinoma resembling tall cell variant of papillary thyroid carcinoma 177
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 175
An original approach in the diagnosis of early breast cancer: use of the same radipharmaceutical for both non palpable lesions and sentinel node localization 172
Biological tissue characterisation in narrow beam x-ray scattering techniques 172
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 171
Increased neurokinin-2 receptor expression in alveolar macrophages of smokers with COPD 170
Oncogenic role of miR-483-3p at the IGF2/483 locus 169
Prevalence of post-stress myocardial stunning by gated-SPECT in diabetic patients: results of a prospective, multi-center trial 167
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 167
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 166
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 165
Role of the miR-501 in Renal Carcinomas 165
Interleukin (IL)-10 expression in non-small cell lung cancer is associated with cigarette smoking 164
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 163
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: Evidence from a retrospective study 163
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 160
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 159
Increased of A3 adenosine receptors by depleted expression of polycystic kidney disease-1 gene (PKD1) in human renal cell and tissues: implication for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells 158
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 158
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 156
Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma) 156
Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer 154
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 152
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 151
Tumor infiltrating lymphocytes in triple negative breast cancer and correlations with prognosis 150
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 150
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 150
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 149
Observational DEMETRA STUDY: survival of metastatic breast carcinoma patients after treatment with Trastuzumab 147
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 143
Sentinel node and bone marrow micro metastases and nanometastases 141
Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision 140
Lymph node micrometastases do influence breast cancer outcome 140
Biological staging of incipient, in situ and invasive breast carcinomas 138
Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. 133
Interobserver reproducibility of immunohistochemical HER-2/neu evaluation in human breast cancer: The real-world experience 128
Pattern of distant recurrence according to the molecular subtypes identified by immunohistochemistry in women with early breast cancer 127
MicroRNAs: toward the clinic for breast cancer patients 125
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 123
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 117
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 117
MicroRNA gene expression deregulation in human breast cancer 112
Tumor infiltrating lymphocyte (TIL) and CD8+ cells in TNBC: new prognostic markers 112
null 111
Macrophage expression of IL-10 is a prognostic factor in non-small cell lung cancer. 110
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 110
I Tissue micro arrays come strumento di ricerca e loro possibile utilizzo nella pratica clinica routinaria 108
null 107
Fattori predittivi del rischio di ulteriore metastatizzazione linfonodale ascellare in pazienti con linfonodo sentinella micrometastatico da tumore della mammella in fase precoce 107
Totale 18.558
Categoria #
all - tutte 80.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 591
Totale 81.185


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021257 0 0 0 0 0 0 0 0 0 0 179 78
2021/20221.285 50 118 70 87 95 52 66 87 52 104 101 403
2022/20231.372 98 113 55 184 263 213 63 126 142 7 67 41
2023/2024729 68 63 45 21 56 167 30 53 8 17 30 171
2024/20253.026 91 84 225 84 376 282 83 154 513 316 448 370
2025/20267.623 814 306 697 1.046 1.258 546 919 378 819 823 17 0
Totale 20.445